How have CPAI shares performed in 2024?

Counterpoint Quantitative Equity ETF's stock was trading at $26.86 at the start of the year. Since then, CPAI shares have increased by 5.9% and is now trading at $28.44. View the best growth stocks for 2024 here .

What does CPAI invest in?

Counterpoint Quantitative Equity ETF is a equity fund issued by Counterpoint Mutual Funds, LLC.. CPAI focuses on strategy investments. The fund's investments total to approximately $21.01 million assets under management.

What is the management fee for Counterpoint Quantitative Equity ETF?

Counterpoint Quantitative Equity ETF's management fee is 0.65% and has other expenses of 1.93%. However, CPAI has a fee waiver of -1.83% to reimburse the expenses. The net expense ratio for CPAI is 0.75%.

Who are Counterpoint Quantitative Equity ETF's major shareholders?

Counterpoint Quantitative Equity ETF's stock is owned by many different institutional and retail investors. Top institutional investors include Counterpoint Mutual Funds LLC (0.00%). View institutional ownership trends .

How do I buy shares of Counterpoint Quantitative Equity ETF?

Shares of CPAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSEARCA:CPAI

Counterpoint Quantitative Equity ETF (CPAI) Price, Holdings, & News

→ Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad)

Free CPAI Stock Alerts

$28.44

+0.01 (+0.04%)

(As of 09:41 AM ET)

Compare

Today's Range: $28.44
▼
$28.44
50-Day Range: $27.09
▼
$29.87
52-Week Range: $25.14
▼
$29.94

Volume: 564 shs
Average Volume: 6,322 shs
Market Capitalization: N/A

Assets Under Management: $21.01 million
Dividend Yield: N/A
Net Expense Ratio: 0.75%

Stock Analysis Chart Holdings Ownership

Get Counterpoint Quantitative Equity ETF alerts:

CPAI Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CPAI ETF News Headlines

June 23, 2023 | msn.com

NFL, NFLPA commit over $500K to fund alternative pain management studies

June 16, 2023 | health.usnews.com

Chiropractic Care During Pregnancy: Is It Safe?

April 18, 2024 | DTI (Ad)

With the “Bitcoin Loophole” you can supercharge the gains by 10x or more

Thanks to this newly discovered Bitcoin Loophole, you can now trade Bitcoin in any regular brokerage account… And not only that… you can use it to supercharge the gains of Bitcoin by 10x or more! You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history. That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords…

May 4, 2023 | yahoo.com

Flipping the script on pain could help stem the opioid crisis

April 7, 2023 | bizjournals.com

These are KCBJ's Champions of Business honorees for 2023

March 12, 2023 | theguardian.com

Champions League report vindicates everything we Liverpool fans fought for

March 10, 2023 | washingtonpost.com

‘Champions’: This comedy’s supporting cast outshines its stars

March 1, 2023 | theguardian.com

Jon Snow has been an outstanding champion of children in care

April 18, 2024 | DTI (Ad)

With the “Bitcoin Loophole” you can supercharge the gains by 10x or more

February 3, 2023 | msn.com

6 Rare Signs You Have A Champion Mentality

See More Headlines

Receive CPAI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Counterpoint Quantitative Equity ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer: Counterpoint Mutual Funds, LLC.
Fund Name: Counterpoint Quantitative Equity ETF
Tax Classification: Regulated Investment Company
Stock Exchange: NYSEARCA
Current Symbol: NYSEARCA:CPAI
Inception Date: 11/28/2023
Fund Manager: Joseph Engelberg, Michael Krause
Web: N/A
Phone: N/A

Fund Focus

Asset Class: Equity
Benchmark: N/A
Category: Broad Equity
Focus: Strategy
Development Level: Developed Markets
Region: North America
Number of Holdings: 51

Fund Statistics

Assets Under Management: $21.01 million
Average Daily Volume: $0.00
Discount/Premium: 0.04%

Administrator, Advisor and Custodian

Administrator: Ultimus Fund Solutions, LLC
Advisor: Counterpoint Mutual Funds, LLC.
Custodian: Brown Brothers Harriman & Co.
Distributor: Northern Lights Distributors, LLC
Transfer Agent: Brown Brothers Harriman & Co.
Trustee: N/A
Lead Market Maker: GTS

Miscellaneous

Outstanding Shares: N/A
Beta: N/A
Creation Unit: 10,000
Creation Fee: $200.00

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Ad Darwin

Your Next Portfolio Star: Revealing 2024's Top Stock Pick

We're thrilled to offer you an exclusive look at the #1 Buy & Hold Stock of 2024. This isn't just any report. It's the culmination of rigorous analysis, expert insights, and cutting-edge financial strategies, distilled into a compelling narrative that charts the course of what we believe to be the year's most promising investment. (**By clicking the link you are subscribing to The Wealth Creation Investing Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)

Click here to download your report

Counterpoint Quantitative Equity ETF Expenses

Type	CPAI	Strategy ETFs	Equity ETFs	NYSEARCA ETFs	All ETFs
Management Fee	0.65%	0.46%	0.54%	0.50%	0.51%
Other Expenses	1.93%	0.42%	0.54%	0.64%	0.58%
Total Expense	2.58%	0.61%	0.70%	0.74%	0.70%
Fee Waiver	-1.83%	-0.44%	-0.55%	-0.68%	-0.57%
Net Expense	0.75%	0.51%	0.60%	0.58%	0.58%

Counterpoint Quantitative Equity ETF (CPAI) Exposure

CPAI Sector Exposure

CPAI Industry Exposure

Full Holdings Details

Similar ETFs

Institutional Ownership

View All Institutional Transactions

CPAI ETF - Frequently Asked Questions

How have CPAI shares performed in 2024?: Counterpoint Quantitative Equity ETF's stock was trading at $26.86 at the start of the year. Since then, CPAI shares have increased by 5.9% and is now trading at $28.44.
View the best growth stocks for 2024 here.
What does CPAI invest in?: Counterpoint Quantitative Equity ETF is a equity fund issued by Counterpoint Mutual Funds, LLC.. CPAI focuses on strategy investments. The fund's investments total to approximately $21.01 million assets under management.
What is the management fee for Counterpoint Quantitative Equity ETF?: Counterpoint Quantitative Equity ETF's management fee is 0.65% and has other expenses of 1.93%. However, CPAI has a fee waiver of -1.83% to reimburse the expenses. The net expense ratio for CPAI is 0.75%.

Who are Counterpoint Quantitative Equity ETF's major shareholders?: Counterpoint Quantitative Equity ETF's stock is owned by many different institutional and retail investors. Top institutional investors include Counterpoint Mutual Funds LLC (0.00%).
View institutional ownership trends.
How do I buy shares of Counterpoint Quantitative Equity ETF?: Shares of CPAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:CPAI) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial